Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

“…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Areas of all BrdU + /Hu+ neurons measured in control birds (dark orange line) and statin-treated birds (light orange line) shows qualitatively that statins did not decrease soma sizes of small cells (overlap of orange lines), and statins did not curtail the upper limit of soma size (light orange line reaches a soma size of > 200 µm, Y axis, top panel). …”

<i>Shroom3</i> myocardial specific loss does not alter postnatal cardiac morphology. by Jennifer L. Carleton (22208916)

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

EF-24 treatment alters gene expression profiles in HL-60 cells. by Ajeet P. Singh (22298432)

Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

“…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

The long-term <i>in vitro</i> surrogate bacterial viability of canine and feline FMT products frozen at -80°C for six months. by Nina K. Randolph (21030732)

A prepubertal CD decreases hepatic lipid accumulation in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness. by Jennifer L. Carleton (22208916)

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

Genetic alterations of CD70 in DLBCL. by Kang Liu (423471)

“…Compared with DLBCL patients with CD70 mutation, methylation levels of PKHD1, MAS1, and FIP1L1 were obviously increased, whereas RPL10A, MARCH10, FAM45A, and FAM45B were significantly decreased in DLBCL patients with CD70 mutation. …”

A prepubertal CD decreases plasma leptin and cholesterol concentrations in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

Subjects:

Leg Stabilization During Measurements arterial occlusion pressure. by Robert Trybulski (10998702)

Subjects:

Example of LDF recording during post-occlusive reactive hyperemia (PORH). by Robert Trybulski (10998702)

Subjects:

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Subjects:

Mean values and 95% confidence intervals for resting flow, arterial occlusion pressure (AOP), biological zero, reactive hyperemia (RHmax), and time to peak across the three conditi... by Robert Trybulski (10998702)

Subjects:

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)